NeueHealth Inc (NEUE)
6.09
-0.07
(-1.14%)
USD |
NYSE |
May 13, 13:52
NeueHealth SG&A Expense (Quarterly): 56.51M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 56.51M |
| September 30, 2023 | 66.20M |
| June 30, 2023 | 64.58M |
| March 31, 2023 | 129.21M |
| December 31, 2022 | 81.12M |
| September 30, 2022 | 77.05M |
| June 30, 2022 | 69.30M |
| March 31, 2022 | 145.28M |
| Date | Value |
|---|---|
| December 31, 2021 | -148.73M |
| September 30, 2021 | 250.14M |
| June 30, 2021 | 202.94M |
| March 31, 2021 | 161.13M |
| December 31, 2020 | 18.51M |
| September 30, 2020 | 72.27M |
| June 30, 2020 | 61.34M |
| March 31, 2020 | 51.41M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
-148.73M
Minimum
Dec 2021
250.14M
Maximum
Sep 2021
84.89M
Average
70.79M
Median
SG&A Expense (Quarterly) Benchmarks
| Clover Health Investments Corp | 103.79M |
| Oscar Health Inc | 394.70M |
| Alignment Healthcare Inc | 90.51M |
| The Cigna Group | 3.705B |
| Centene Corp | 3.218B |